Skip to content

Coherus Oncology, Inc.: filings

Every Coherus Oncology, Inc. annual and quarterly report in the SEC record with the published financial measures it tagged, 48 filings, each linked to its SEC index.

Filings with published measures

Each page shows what one filing reported, as tagged in that filing, with the periods it covered. Later filings can restate a value; the company overview shows the latest-filed value per period.

FormFiledFiscal periodMeasuresFactsSEC accession
10-Q2026-08-05fiscal Q2 2026381110001104659-26-091262
10-Q2026-05-11fiscal Q1 202638790001104659-26-058703
10-K2026-03-09fiscal FY 202547950001104659-26-025308
10-Q2025-11-06fiscal Q3 2025391180001104659-25-107852
10-Q2025-08-07fiscal Q2 2025391140001558370-25-010803
10-Q2025-05-12fiscal Q1 202539820001558370-25-007418
10-K2025-03-17fiscal FY 2024481190001558370-25-003126
10-Q2024-11-06fiscal Q3 2024411210001558370-24-014648
10-Q2024-08-08fiscal Q2 2024401150001558370-24-011629
10-Q2024-05-09fiscal Q1 202439830001558370-24-007641
10-K2024-03-15fiscal FY 2023481230001558370-24-003436
10-Q2023-11-06fiscal Q3 2023411210001558370-23-017779
10-Q2023-08-02fiscal Q2 2023371100001558370-23-012915
10-Q2023-05-08fiscal Q1 202337800001558370-23-008529
10-K2023-03-06fiscal FY 2022471190001558370-23-002917
10-Q2022-11-08fiscal Q3 2022371090001558370-22-016850
10-Q2022-08-04fiscal Q2 2022371050001558370-22-012251
10-Q2022-05-05fiscal Q1 202236780001558370-22-007420
10-K2022-02-23fiscal FY 2021451150001558370-22-001764
10-Q2021-11-08fiscal Q3 2021391150001558370-21-015033
10-Q2021-08-05fiscal Q2 2021401130001558370-21-010563
10-Q2021-05-06fiscal Q1 202141880001558370-21-006257
10-K2021-02-25fiscal FY 2020441130001558370-21-001829
10-Q2020-11-05fiscal Q3 2020401130001558370-20-012864
10-Q2020-08-06fiscal Q2 2020421160001558370-20-009657
10-Q2020-05-07fiscal Q1 202043880001558370-20-005749
10-K2020-02-27fiscal FY 2019511660001564590-20-007416
10-Q2019-11-08fiscal Q3 2019441310001564590-19-042255
10-Q2019-08-05fiscal Q2 2019461310001564590-19-028841
10-Q2019-05-09fiscal Q1 201940810001564590-19-018007
10-K2019-02-28fiscal FY 2018421370001564590-19-005470
10-Q2018-11-08fiscal Q3 201836920001564590-18-028562
10-Q2018-08-08fiscal Q2 201836920001564590-18-020492
10-Q2018-05-10fiscal Q1 201832660001564590-18-012976
10-K2018-03-08fiscal FY 2017371180001564590-18-004947
10-Q2017-11-06fiscal Q3 201736990001564590-17-021844
10-Q2017-08-07fiscal Q2 201732830001564590-17-016017
10-Q2017-05-08fiscal Q1 201732660001564590-17-009394
10-K2017-03-14fiscal FY 2016381200001564590-17-004176
10-Q2016-11-09fiscal Q3 2016361000001564590-16-028634
10-Q2016-08-09fiscal Q2 201633860001564590-16-023684
10-Q2016-05-09fiscal Q1 201633670001564590-16-018615
10-K2016-02-29fiscal FY 2015351110001564590-16-013726
10-Q2015-11-10fiscal Q3 201535900001564590-15-010330
10-Q2015-08-10fiscal Q2 201536920001564590-15-006845
10-Q2015-05-11fiscal Q1 201536710001564590-15-003938
10-K2015-03-23fiscal FY 2014361070001564590-15-001896
10-Q2014-12-15fiscal Q3 201434880001564590-14-006207

Inspect the source

Entity
Coherus Oncology, Inc. / CIK 0001512762
Captured
2026-09-20T09:13:09.943Z
SEC response SHA-256
5c5765981b2a86ba6afe797bbe14b15cb57f0db8164b0eb431640837c7af90f8

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001512762.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))